StockXETRABAYN.DE

Bayer

€50.10

+0.64 (+1.29%)today

Valuation & earnings

Forward P/E: 10.38
EPS (ttm): -€1.76
Forward EPS: €4.83
Price/book: 1.66
PEG ratio: 4.65
Dividend yield: 22%
Payout ratio: 163.27%

Financials (ttm)

Revenue (ttm): 45.4B
Revenue growth: 1.2%
Profit margin: -3.83%
Return on equity: -5.69%
Total cash: 5.1B
Total debt: 38.4B

Earnings (EPS)

Quarter	Estimate	Actual	Surprise
Sep 30, 2025	0.32	0.57	+75.45%
Dec 31, 2025	0.49	0.62	+27.04%
Mar 31, 2026	2.25	2.71	+20.62%
Jun 30, 2026	0.75	0.95	+27.28%

Next earnings date: Nov 3, 2026

Analyst view

Consensus ratingBuy18 analysts

Strong buy 5Buy 8Hold 4Strong sell 1

12-month price targetsImplied upside: +16.21%

58.22

LowCurrent priceHigh

Dividends

Dividend yield: 22%
Dividend (annual): €0.11
Ex-dividend date: Apr 27, 2026

Recent payments

Apr 26, 2026 · €0.11Apr 27, 2025 · €0.11Apr 28, 2024 · €0.11May 1, 2023 · €2.40May 1, 2022 · €2.00

Key stats

Previous close: €49.46
Day range: 49.16 – 50.32
52-week range: 25.78 – 53.92
Volume: 1.1M
Avg. volume: 2.4M
Market cap: 49.2B
Beta: 0.83
52-week change: 81.21%
Currency: EUR

Profile

Bayer Aktiengesellschaft operates as a life science company in Europe, the Middle East, Africa, Germany, Switzerland, North America, the United States, the Asia Pacific, China, Latin America, and Brazil. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment provides prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and contrast agents, as well as cell and gene therapy. The Consumer Health segment offers non(English)

Sector: Healthcare
Industry: Drug Manufacturers - General
Employees: 87,830
Headquarters: Leverkusen, Germany

Visit website

Market data provided by Yahoo Finance, may be delayed. For informational purposes only — not investment advice.